Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Identification, optimization and use of cryptic HLA-B7 epitopes for immunotherapy

Identification, optimization and use of cryptic HLA-B7 epitopes for immunotherapy

US Patent 8465747 · Granted Jun 18, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of a vaccine targeting a cryptic tert epitope, for treating cancer in a HLA-2024
Use of a vaccine targeting a cryptic tert epitope, for treating cancer in a HLA-2024
Identification, optimization and use of shared HLA-B*0702 epitopes for immunothe2018
Identification, optimization and use of shared HLA-B*0702 epitopes for immunothe2018
Identification, optimization and use of cryptic HLA-A24 epitopes for immunothera2014
Identification, optimization and use of cryptic HLA-A24 epitopes for immunothera2014
Use of native peptides and their optimized derivatives for vaccination2014
Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereo2011
Polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereo2011
Immunogenic polypeptide composed of tumor antigen-derived optimized cryptic pept2011
Peptide epitopes common to antigens of the same multigene family2008